Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation.
about
Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cellsCytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.Infections in the immunosuppressed hostUsefulness of immune monitoring in lung transplantation using adenosine triphosphate production in activated lymphocytes.Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndromeStaphylococcus via an interaction with the ELR+ CXC chemokine ENA-78 is associated with BOS.Lung Infection by Human Bocavirus Induces the Release of Profibrotic Mediator Cytokines In Vivo and In VitroIncidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft DysfunctionBronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation.CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction.CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality.Viral infections in lung transplant recipients.NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma.Lung transplantation: infection, inflammation, and the microbiome.Is prevention the best treatment? CMV after lung transplantation.Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.Infectious Triggers of Chronic Lung Allograft Dysfunction.Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation.Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.Role of cytokine profile in the differential diagnosis between acute lung rejection and pulmonary infections after lung transplantation†.Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction.High CXCL-16 levels correlate with symptomatic disease in lung transplant recipients with human cytomegalovirus replication in the allograft.CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation.Gene Expression Profiling of Bronchoalveolar Lavage Cells during Aspergillus Colonization of the Lung Allograft.Cytomegalovirus Replication Within the Lung Allograft Is Associated With Bronchiolitis Obliterans Syndrome
P2860
Q33627550-54A1FC2F-55A8-4097-9678-FCFD51DA609EQ33950112-E704CA76-935D-4EA1-B95C-1A1F70E680FAQ34357428-6C130CFB-7116-4620-988F-11066DCEFA25Q34378856-4383D30B-3F54-4926-B1CE-067040705D61Q34427034-47727BCB-3528-49B4-80E6-B3E131D7DC82Q35106913-D8372B0F-90BA-48FF-9888-9CA9EFD348C6Q35903156-978349BC-5F57-40CC-A4A6-A6A2DD087853Q35946563-B7979E56-0191-4553-8991-1E94487E6BADQ36253928-C9B95355-C1AA-4D00-BF9D-C8FFBBF5B608Q36623201-1E9FE581-134B-42AF-83F8-A48384A7D696Q37069999-AA62BFA6-942C-4EA7-9F19-C678EA290C68Q37322659-746EC807-D6AF-4B60-ADF6-41C8D8FF326DQ37393663-8EBD0D93-3D75-4FA0-A3E5-9B25F72321C1Q37616717-0E63DDE5-2ABD-4D09-97FD-1D1C41735941Q37721885-4CCE4D64-E8C2-4188-8954-27C24231BC02Q37729643-D8A4729C-5DA6-442D-8359-0F8AC390CB42Q37832677-E4D22136-A082-4A85-BD65-73E7F4E5BAC3Q37954420-56C2D1F4-F6B6-405F-8411-EE4503D26195Q38168278-A9CD5AC4-B7DC-4C23-B527-7FAD18A518FDQ38843601-EA33A92C-A6F8-4A6C-AC1A-D1D31B04B6EEQ39638382-8ECCCB8C-66D0-49AE-80E7-24D7FC0DD0DFQ40476574-2974274A-1940-4CF7-A574-BA3EC56C5414Q41688914-A0706932-8F3C-4E17-8077-C5FB3490D6A3Q41930789-EAF61F9D-4ED8-4CF3-884F-9D978897728BQ42198626-C0CEF024-33D4-4375-85C4-1AA3A197E9C0Q42559685-6939CDFD-372F-4840-9BE7-4021F3D662C8Q52739417-6CF063CD-7A19-4AEC-84D8-DC14694473CBQ59263071-143B53AF-E87D-4B98-AD37-EC358A934111
P2860
Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Altered levels of CC chemokine ...... ity post-lung transplantation.
@ast
Altered levels of CC chemokine ...... ity post-lung transplantation.
@en
type
label
Altered levels of CC chemokine ...... ity post-lung transplantation.
@ast
Altered levels of CC chemokine ...... ity post-lung transplantation.
@en
prefLabel
Altered levels of CC chemokine ...... ity post-lung transplantation.
@ast
Altered levels of CC chemokine ...... ity post-lung transplantation.
@en
P2093
P2860
P1476
Altered levels of CC chemokine ...... ity post-lung transplantation.
@en
P2093
A Ardehali
B N Gomperts
D A Zisman
J A Belperio
M C Fishbein
R M Elashoff
P2860
P304
P356
10.1111/J.1600-6143.2008.02280.X
P407
P50
P577
2008-07-01T00:00:00Z